Many different diseases and disorder can affect the human’s lungs. The problem with figuring out solution is the fact that the lung might hold tiny spaces where imaging technology is not yet available for. These diseases could be fatal and might need fast care.
A new study, conducted by the National Heart Lung and Blood Institution has found a method to start imaging such disorders. The main disease under study is the Chronic Obstructive Pulmonary Disease (COPD) which is an inflammation which affects the lungs. This is a very common diseases, affecting almost 16 million people in the United States becoming the fourth leading cause of death.
The problem with identifying the disease is the fact that it affects tiny areas in the lungs which is hard to observe. However, this new study has introduced a non-invasive imagine technique which can actually validate the presence of the disease in the tiny airways of the lungs.
Lead researcher and Ph.D. holder Brian Ross is the professor of radiology and biological chemistry. He worked hand in hand with Ph.D. holder Craig Galban, which is a professor of radiology and published their study in the American Journal of Respiratory and Critical Care.
According to results they obtained from tissue analysis of patients, they compared the samples with CT scans and were able to mirror areas which resemble the disease. The study states, “Now we have confidence in our ability to identify airway disease when imaging COPD patients. PRM is already clinically available and used by University of Michigan clinical teams to assess patients with COPD. This is what we mean by bench to bedside medicine.”